SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Cistron Biotechnology(CIST)$.30
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: PeterR1700 who wrote (1790)12/9/1998 9:52:00 AM
From: Walter Morton  Read Replies (1) of 2742
 
Well, I think CIST lacks the desire and ability to market its product and grow its company profitably. So, I have suggested that CIST grow, improve its marketing skills and profitability by using its cash to acquire a company that has the skills that CIST currently seems to lack.

HMGM seems to be a very good match relative to price: $12 in sales, profitable, growing, and only $.8125/share yesterday.

ENDG is too expensive.
BIOI is not profitable.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News